(1)
An Explorative Study of Oral Microemulsion-Based Formulation for the Delivery of Cabazitaxel and Piperine. Int. J. Pharm. Sci. Drug Res. 2022, 14 (3), 351-357. https://doi.org/10.25004/IJPSDR.2022.140307.